☰

John H. Kempen, Ph.D. - Publications

Affiliations: 
2001 Johns Hopkins University, Baltimore, MD 
Area:
Ophthalmology, Public Health
Tree Info Similar researchers PubMed Report error

113 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tomkins-Netzer O, Lightman SL, Burke AE, Sugar EA, Lim LL, Jaffe GJ, Altaweel MM, Kempen JH, Holbrook JT, Jabs DA. Seven-year outcomes of uveitic macular edema: the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study results. Ophthalmology. PMID 32918964 DOI: 10.1016/J.Ophtha.2020.08.035  0.408
2020 Sudharshan S, Nair N, Curi A, Banker A, Kempen JH. Human immunodeficiency virus and intraocular inflammation in the era of highly active anti retroviral therapy - An update. Indian Journal of Ophthalmology. 68: 1787-1798. PMID 32823395 DOI: 10.4103/Ijo.Ijo_1248_20  0.369
2020 Kempen JH, Van Natta ML, Friedman DS, Altaweel MM, Ansari H, Dunn JP, Elner SG, Holbrook JT, Lim LL, Sugar EA, Jabs DA. Incidence and outcome of uveitic glaucoma in eyes with intermediate, posterior or panuveitis followed up to 10 years after randomization to fluocinolone acetonide implant or systemic therapy. American Journal of Ophthalmology. PMID 32628922 DOI: 10.1016/J.Ajo.2020.06.038  0.383
2020 Shah DN, Al-Moujahed A, Newcomb CW, Kaçmaz RO, Daniel E, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Bhatt NP, Kempen JH, et al. Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive Factors. American Journal of Ophthalmology. PMID 32621891 DOI: 10.1016/J.Ajo.2020.06.019  0.344
2020 Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, Kempen JH, Gupta A, Smith JR, de Smet MD, Yuen YS, Mahajan S, Kon OM, Nguyen QD, Pavesio C, et al. Collaborative Ocular Tuberculosis Study (COTS) Consensus Guidelines on the Management of Tubercular Uveitis - Report 2: Guidelines for Initiating Anti-Tubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis and Retinal Vasculitis. Ophthalmology. PMID 32603726 DOI: 10.1016/J.Ophtha.2020.06.052  0.329
2020 Agrawal R, Gunasekeran DV, Agarwal A, Testi I, Carreño E, Westcott M, Mahajan S, Raje D, Aggarwal K, Murthy SI, Chee SP, Mccluskey P, Ho SL, Teoh S, Cimino L, ... ... Kempen JH, et al. Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6. Ocular Immunology and Inflammation. 1-9. PMID 32600169 DOI: 10.1080/09273948.2020.1774905  0.324
2020 Agrawal R, Betzler B, Testi I, Mahajan S, Agarwal A, Gunasekeran DV, Raje D, Aggarwal K, Murthy SI, Westcott M, Chee SP, Mccluskey P, Ho SL, Teoh S, Cimino L, ... ... Kempen JH, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients with Tubercular Anterior Uveitis. Ocular Immunology and Inflammation. 1-10. PMID 32600163 DOI: 10.1080/09273948.2020.1761400  0.342
2020 Agrawal R, Testi I, Lee CS, Tsui E, Blazes M, Thorne JE, Okada AA, Smith JR, McCluskey PJ, Kempen JH, Christoph T, Agarwal M, Bodaghi B, Nguyen QD, Gupta V, et al. Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic. The British Journal of Ophthalmology. PMID 32586933 DOI: 10.1136/Bjophthalmol-2020-316776  0.327
2020 Thng ZX, De Smet MD, Lee CS, Gupta V, Smith JR, McCluskey PJ, Thorne JE, Kempen JH, Zierhut M, Nguyen QD, Pavesio C, Agrawal R. COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs. The British Journal of Ophthalmology. PMID 32532764 DOI: 10.1136/Bjophthalmol-2020-316586  0.342
2020 Peters RPH, Kestelyn PG, Zierhut M, Kempen JH. The Changing Global Epidemic of HIV and Ocular Disease. Ocular Immunology and Inflammation. 1-8. PMID 32396027 DOI: 10.1080/09273948.2020.1751214  0.365
2020 Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Rousselot A, Raje D, Gunasekeran DV, Kon OM, Barisani-Asenbauer T, Kempen JH, Gupta A, Jabs DA, Smith JR, Bodaghi B, et al. The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings. Ocular Immunology and Inflammation. 1-11. PMID 32250731 DOI: 10.1080/09273948.2020.1716025  0.315
2020 Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM, Barisani-Asenbauer T, Kempen JH, Gupta A, Jabs DA, Smith JR, Nguyen QD, Pavesio C, Gupta V. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis. Ophthalmology. PMID 32115264 DOI: 10.1016/J.Ophtha.2020.01.008  0.31
2019 Agrawal R, Agarwal A, Jabs DA, Kee A, Testi I, Mahajan S, McCluskey PJ, Gupta A, Palestine A, Denniston A, Banker A, Invernizzi A, Fonollosa A, Sharma A, Kumar A, ... ... Kempen J, et al. Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop. Ocular Immunology and Inflammation. 1-11. PMID 31821096 DOI: 10.1080/09273948.2019.1653933  0.305
2019 Pistilli M, Joffe MM, Gangaputra SS, Pujari SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Begum H, Fitzgerald TD, ... ... Kempen JH, et al. Visual Acuity Outcome over Time in Non-Infectious Uveitis. Ocular Immunology and Inflammation. 1-8. PMID 31821051 DOI: 10.1080/09273948.2019.1687733  0.394
2019 Testi I, Agrawal R, Mahajan S, Agarwal A, Gunasekeran DV, Raje D, Aggarwal K, Murthy SI, Westcott M, Chee SP, McCluskey P, Ho SL, Teoh S, Cimino L, Biswas J, ... ... Kempen J, et al. Tubercular Uveitis: Nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1. Ocular Immunology and Inflammation. 1-9. PMID 31763952 DOI: 10.1080/09273948.2019.1646774  0.331
2019 Neumann R, Nguyen QD, Kramer M, Zierhut M, Kempen JH, DeSmet M, Wickstrom K. ISOPT Hot Topic Panel Discussion on Uveitis and Inflammation. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 35: 433-440. PMID 31596666 DOI: 10.1089/Jop.2019.0035  0.312
2019 Tolesa K, Abateneh A, Kempen JH, Gelaw Y. Patterns of Uveitis among Patients Attending Jimma University Department of Ophthalmology, Jimma, Ethiopia. Ocular Immunology and Inflammation. 1-7. PMID 31429610 DOI: 10.1080/09273948.2019.1644348  0.352
2018 Thorne JE, Sugar EA, Holbrook JT, Burke AE, Altaweel MM, Vitale AT, Acharya NR, Kempen JH, Jabs DA. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial. Ophthalmology. PMID 30269924 DOI: 10.1016/J.Ophtha.2018.08.021  0.34
2018 Kempen JH, Tekle-Haimanot R, Hunduma L, Alemayehu M, Pistilli M, Abashawl A, Lawrence SD, Alemayehu W. Fluorometholone 0.1% as Ancillary Therapy for Trachomatous Trichiasis Surgery: Randomized Clinical Trial. American Journal of Ophthalmology. PMID 30267699 DOI: 10.1016/J.Ajo.2018.09.017  0.357
2018 Agrawal R, Gunasekeran DV, Agarwal A, Carreño E, Aggarwal K, Gupta B, Raje D, Murthy SI, Westcott M, Chee SP, McCluskey P, Ling HS, Teoh S, Cimino L, Biswas J, ... ... Kempen J, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Description of the Spectrum of Choroidal Involvement in 245 Patients with Tubercular Uveitis. Ocular Immunology and Inflammation. 1-11. PMID 30156979 DOI: 10.1080/09273948.2018.1489061  0.306
2018 O'Neil EC, Huang J, Suhler EB, Dunn JP, Perez VL, Gritz DC, McWilliams K, Peskin E, Ying GS, Bunya VY, Maguire MG, Kempen JH. Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial. The British Journal of Ophthalmology. PMID 29666122 DOI: 10.1136/Bjophthalmol-2017-311610  0.331
2017 Kempen JH, Altaweel MM, Holbrook JT, Sugar EA, Thorne JE, Jabs DA. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis. Jama. PMID 28477440 DOI: 10.1001/Jama.2017.5103  0.383
2016 Altaweel MM, Gangaputra SS, Thorne JE, Dunn JP, Elner SG, Jaffe GJ, Kim RY, Rao PK, Reed SB, Kempen JH. Morphological assessment of the retina in uveitis. Journal of Ophthalmic Inflammation and Infection. 6: 33. PMID 27613274 DOI: 10.1186/S12348-016-0103-2  0.364
2016 Durrani K, Kempen JH, Ying GS, Kacmaz RO, Artornsombudh P, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Foster CS, Site Research Group. Adalimumab for Ocular Inflammation. Ocular Immunology and Inflammation. 1-8. PMID 27003323 DOI: 10.3109/09273948.2015.1134581  0.436
2016 Kempen JH, Gewaily DY, Newcomb CW, Liesegang TL, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Payal A, Fitzgerald TD, et al. Remission of Intermediate Uveitis: Incidence and Predictive Factors. American Journal of Ophthalmology. PMID 26772874 DOI: 10.1016/J.Ajo.2015.12.034  0.425
2015 Patel AK, Newcomb CW, Liesegang TL, Pujari SS, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Artornsombudh P, Kothari S, Kempen JH, et al. Risk of Retinal Neovascularization in Cases of Uveitis. Ophthalmology. PMID 26686964 DOI: 10.1016/J.Ophtha.2015.10.056  0.436
2015 Li J, Orlin SE, Revere KE, Kempen JH. Acute onset anterior uveitis after darbepoetin alfa infusion. Journal of Ophthalmic Inflammation and Infection. 5: 31. PMID 26502332 DOI: 10.1186/S12348-015-0061-0  0.391
2015 Sen HN, Abreu FM, Louis TA, Sugar EA, Altaweel MM, Elner SG, Holbrook JT, Jabs DA, Kim RY, Kempen JH. Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial. Ophthalmology. PMID 26499920 DOI: 10.1016/J.Ophtha.2015.09.022  0.398
2015 Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. American Journal of Ophthalmology. PMID 26386159 DOI: 10.1016/J.Ajo.2015.09.017  0.384
2015 Tomkins-Netzer O, Lightman S, Drye L, Kempen J, Holland GN, Rao NA, Stawell RJ, Vitale A, Jabs DA. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results. Ophthalmology. 122: 2351-9. PMID 26359188 DOI: 10.1016/J.Ophtha.2015.07.036  0.433
2015 Kempen JH, Jabs DA. Quality of life and risks associated with systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, or panuveitis: Fifty-four-month results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Ophthalmology. 122: 1976-1986. PMID 26298718 DOI: 10.1016/J.Ophtha.2015.06.043  0.367
2015 Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. Ophthalmology. 122: 1967-75. PMID 26298715 DOI: 10.1016/J.Ophtha.2015.06.042  0.324
2015 Kothari S, Foster CS, Pistilli M, Liesegang TL, Daniel E, Sen HN, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Lawrence SD, Kempen JH. The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis. Ophthalmology. 122: 1987-2001. PMID 26233626 DOI: 10.1016/J.Ophtha.2015.06.041  0.42
2015 Ganesh SK, Bala A, Biswas J, Ahmed AS, Kempen JH. Pattern of Pediatric Uveitis Seen at a Tertiary Referral Center from India. Ocular Immunology and Inflammation. 1-8. PMID 26171572 DOI: 10.3109/09273948.2015.1012298  0.376
2015 Mehta S, Kempen JH. Cataract surgery in patients with uveitis. International Ophthalmology Clinics. 55: 133-9. PMID 26035765 DOI: 10.1097/Iio.0000000000000078  0.327
2015 Lerman MA, Lewen MD, Kempen JH, Mills MD. Uveitis Reactivation in Children Treated With Tumor Necrosis Factor Alpha Inhibitors. American Journal of Ophthalmology. 160: 193-200.e1. PMID 25892124 DOI: 10.1016/J.Ajo.2015.04.016  0.319
2015 Khachatryan N, Kempen JH. Immunosuppressive therapy and cancer risk in ocular inflammation patients: fresh evidence and more questions. Ophthalmology. 122: 219-21. PMID 25618424 DOI: 10.1016/J.Ophtha.2014.11.023  0.322
2014 Kempen JH, Sugar EA, Varma R, Dunn JP, Heinemann MH, Jabs DA, Lyon AT, Lewis RA. Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections. Ophthalmology. 121: 2317-24. PMID 25109932 DOI: 10.1016/J.Ophtha.2014.06.014  0.432
2014 Choe CH, McArthur GA, Caro I, Kempen JH, Amaravadi RK. Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib. American Journal of Ophthalmology. 158: 831-837.e2. PMID 25036880 DOI: 10.1016/J.Ajo.2014.07.003  0.382
2014 Sen HN, Vitale S, Gangaputra SS, Nussenblatt RB, Liesegang TL, Levy-Clarke GA, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Kempen JH. Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology. 121: 2275-86. PMID 25017415 DOI: 10.1016/J.Ophtha.2014.05.021  0.485
2014 Mehta S, Linton MM, Kempen JH. Outcomes of cataract surgery in patients with uveitis: a systematic review and meta-analysis. American Journal of Ophthalmology. 158: 676-692.e7. PMID 24983790 DOI: 10.1016/J.Ajo.2014.06.018  0.436
2014 Eftekhari K, Ghodasra DH, Haynes K, Chen J, Kempen JH, VanderBeek BL. Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study. Pharmacoepidemiology and Drug Safety. 23: 745-52. PMID 24757075 DOI: 10.1002/Pds.3623  0.316
2014 Artornsombudh P, Pistilli M, Foster CS, Pujari SS, Gangaputra SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH. Factors predictive of remission of new-onset anterior uveitis. Ophthalmology. 121: 778-84. PMID 24342020 DOI: 10.1016/J.Ophtha.2013.09.041  0.415
2014 Levin MH, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH. Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema. Ophthalmology. 121: 588-95.e1. PMID 24332536 DOI: 10.1016/J.Ophtha.2013.09.023  0.406
2013 Joffe MM, Pistilli M, Kempen JH. Marginal structural models for comparing alternative treatment strategies in ophthalmology using observational data. Ophthalmic Epidemiology. 20: 197-200. PMID 23819465 DOI: 10.3109/09286586.2013.792939  0.31
2013 Baxter SL, Pistilli M, Pujari SS, Liesegang TL, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Kempen JH. Risk of choroidal neovascularization among the uveitides. American Journal of Ophthalmology. 156: 468-77.e2. PMID 23795984 DOI: 10.1016/J.Ajo.2013.04.040  0.441
2013 Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, Lightman SL, Thorne JE, Vitale AT, Altaweel MM. Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology. 120: 1852-9. PMID 23706700 DOI: 10.1016/J.Ophtha.2013.01.069  0.371
2013 Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, Katz J, Thorne JE, Lightman SL, Kempen JH. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology. 120: 1571-9. PMID 23601801 DOI: 10.1016/J.Ophtha.2013.01.025  0.377
2013 Mehta S, Hariharan L, Ho AC, Kempen JH. Peripapillary choroidal neovascularization in pars planitis. Journal of Ophthalmic Inflammation and Infection. 3: 13. PMID 23514324 DOI: 10.1186/1869-5760-3-13  0.38
2013 Gregory AC, Kempen JH, Daniel E, Kaçmaz RO, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology. 120: 186-92. PMID 23062650 DOI: 10.1016/J.Ophtha.2012.07.052  0.477
2012 Khairallah M, Accorinti M, Muccioli C, Kahloun R, Kempen JH. Epidemiology of Behçet disease. Ocular Immunology and Inflammation. 20: 324-35. PMID 23030353 DOI: 10.3109/09273948.2012.723112  0.391
2012 Kempen JH, Sugar EA, Lyon AT, Lewis RA, Jabs DA, Heinemann MH, Dunn JP. Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome. Ophthalmology. 119: 2343-50. PMID 22853972 DOI: 10.1016/J.Ophtha.2012.05.044  0.464
2012 Daniel E, Pistilli M, Pujari SS, Kaçmaz RO, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH. Risk of hypotony in noninfectious uveitis. Ophthalmology. 119: 2377-85. PMID 22796306 DOI: 10.1016/J.Ophtha.2012.05.032  0.374
2012 Taylor SR, Lightman SL, Sugar EA, Jaffe GJ, Freeman WR, Altaweel MM, Kozak I, Holbrook JT, Jabs DA, Kempen JH. The impact of macular edema on visual function in intermediate, posterior, and panuveitis. Ocular Immunology and Inflammation. 20: 171-81. PMID 22530874 DOI: 10.3109/09273948.2012.658467  0.315
2012 Udoetuk JD, Dai Y, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH. Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases. Ophthalmology. 119: 1569-74. PMID 22484116 DOI: 10.1016/J.Ophtha.2012.01.043  0.392
2012 Charkoudian LD, Ying GS, Pujari SS, Gangaputra S, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Kempen JH. High-dose intravenous corticosteroids for ocular inflammatory diseases. Ocular Immunology and Inflammation. 20: 91-9. PMID 22409561 DOI: 10.3109/09273948.2011.646382  0.406
2012 Lerman MA, Mills M, Joffe M, Finkel TH, Hennessy S, Kempen JH. Response of pediatric uveitis to TNFα inhibitors Pediatric Rheumatology. 10. DOI: 10.1186/1546-0096-10-S1-A79  0.386
2011 Gangaputra SS, Altaweel MM, Peng Q, Friedman DS, Rao PK, Foster CS, Kim RY, Reed SB, Srivastava SK, Wong IG, Kempen JH. Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial. Ocular Immunology and Inflammation. 19: 267-74. PMID 21770805 DOI: 10.3109/09273948.2011.583376  0.346
2011 Grunwald L, Newcomb CW, Daniel E, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH. Risk of relapse in primary acute anterior uveitis. Ophthalmology. 118: 1911-5. PMID 21680024 DOI: 10.1016/J.Ophtha.2011.02.044  0.364
2011 Kempen JH. The need for a revised approach to epidemiological monitoring of the prevalence of visual impairment. Ophthalmic Epidemiology. 18: 99-102. PMID 21609237 DOI: 10.3109/09286586.2011.588908  0.382
2011 Rathinam SR, Krishnadas R, Ramakrishnan R, Thulasiraj RD, Tielsch JM, Katz J, Robin AL, Kempen JH. Population-based prevalence of uveitis in Southern India. The British Journal of Ophthalmology. 95: 463-7. PMID 20693551 DOI: 10.1136/Bjo.2010.182311  0.36
2010 Galor A, Feuer W, Kempen JH, Kaçmaz RO, Liesegang TL, Suhler EB, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Thorne JE. Adverse effects of smoking on patients with ocular inflammation. The British Journal of Ophthalmology. 94: 848-53. PMID 20606023 DOI: 10.1136/Bjo.2009.174466  0.325
2010 Ansari H, Kempen JH. Proof of concept for combined insertion of fluocinolone acetonide and glaucoma drainage implants for eyes with uveitis and glaucoma. American Journal of Ophthalmology. 149: 699-700. PMID 20399922 DOI: 10.1016/J.Ajo.2010.03.001  0.354
2010 Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Mycophenolate mofetil for ocular inflammation. American Journal of Ophthalmology. 149: 423-32.e1-2. PMID 20042178 DOI: 10.1016/J.Ajo.2009.09.026  0.449
2010 Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Foster CS. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 117: 576-84. PMID 20031223 DOI: 10.1016/J.Ophtha.2009.08.010  0.411
2010 Zaidi AA, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH. Hypopyon in patients with uveitis. Ophthalmology. 117: 366-72. PMID 20006905 DOI: 10.1016/J.Ophtha.2009.07.025  0.434
2010 Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Foster CS. Cyclophosphamide for ocular inflammatory diseases. Ophthalmology. 117: 356-65. PMID 19969366 DOI: 10.1016/J.Ophtha.2009.06.060  0.408
2010 Otiti-Sengeri J, Colebunders R, Kempen JH, Ronald A, Sande M, Katabira E. The prevalence and causes of visual loss among HIV-infected individuals in Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). 53: 95-101. PMID 19927007 DOI: 10.1097/Qai.0B013E3181C313F0  0.383
2009 Watkins AS, Kempen JH, Choi D, Liesegang TL, Pujari SS, Newcomb C, Nussenblatt RB, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Suhler EB, Smith JR. Ocular disease in patients with ANCA-positive vasculitis. Journal of Ocular Biology, Diseases, and Informatics. 3: 12-19. PMID 20835396 DOI: 10.1007/S12177-009-9044-4  0.389
2009 Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH. Methotrexate for ocular inflammatory diseases. Ophthalmology. 116: 2188-98.e1. PMID 19748676 DOI: 10.1016/J.Ophtha.2009.04.020  0.44
2009 Kempen JH, Daniel E, Dunn JP, Foster CS, Gangaputra S, Hanish A, Helzlsouer KJ, Jabs DA, Kaçmaz RO, Levy-Clarke GA, Liesegang TL, Newcomb CW, Nussenblatt RB, Pujari SS, Rosenbaum JT, et al. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. Bmj (Clinical Research Ed.). 339: b2480. PMID 19578087 DOI: 10.1136/Bmj.B2480  0.301
2009 Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Suhler EB. Azathioprine for ocular inflammatory diseases. American Journal of Ophthalmology. 148: 500-509.e2. PMID 19570522 DOI: 10.1016/J.Ajo.2009.05.008  0.397
2008 Ssemanda E, Lindsley K, Ervin AM, Kempen J. Comparison of intraocular lens types for cataract surgery in eyes with uveitis. The Cochrane Database of Systematic Reviews. 2008. PMID 25013384 DOI: 10.1002/14651858.Cd007284  0.729
2008 Otiti-Sengeri J, Meenken C, van den Horn GJ, Kempen JH. Ocular immune reconstitution inflammatory syndromes. Current Opinion in Hiv and Aids. 3: 432-7. PMID 19373002 DOI: 10.1097/Coh.0B013E328302Cc3D  0.38
2008 Kempen JH. Medical management of human immunodeficiency virus infection. Indian Journal of Ophthalmology. 56: 385-90. PMID 18711266 DOI: 10.4103/0301-4738.42414  0.351
2008 Kaçmaz RO, Kempen JH, Newcomb C, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Foster CS. Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. American Journal of Ophthalmology. 146: 828-36. PMID 18708181 DOI: 10.1016/J.Ajo.2008.06.019  0.463
2008 Kempen JH, Ganesh SK, Sangwan VS, Rathinam SR. Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. American Journal of Ophthalmology. 146: 813-8.e1. PMID 18687418 DOI: 10.1016/J.Ajo.2008.06.004  0.321
2008 Kempen JH, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Helzlsouer KJ. Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. American Journal of Ophthalmology. 146: 802-12.e1. PMID 18579112 DOI: 10.1016/J.Ajo.2008.04.035  0.332
2008 Kempen JH, Daniel E, Gangaputra S, Dreger K, Jabs DA, Kaçmaz RO, Pujari SS, Anzaar F, Foster CS, Helzlsouer KJ, Levy-Clarke GA, Nussenblatt RB, Liesegang T, Rosenbaum JT, Suhler EB. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiology. 15: 47-55. PMID 18300089 DOI: 10.1080/09286580701585892  0.391
2007 Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology. 114: 780-6. PMID 17258320 DOI: 10.1016/J.Ophtha.2006.11.008  0.356
2007 Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology. 114: 787-93. PMID 17210182 DOI: 10.1016/J.Ophtha.2006.07.065  0.414
2007 Thorne JE, Holbrook JT, Jabs DA, Kempen JH, Nichols C, Meinert CL. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology. 114: 591-8. PMID 17123624 DOI: 10.1016/J.Ophtha.2006.08.008  0.432
2006 Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 113: 1441-5. PMID 16781775 DOI: 10.1016/J.Ophtha.2006.03.022  0.386
2006 Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 113: 1432-40. PMID 16766032 DOI: 10.1016/J.Ophtha.2006.03.021  0.405
2006 Daniel E, Ffytche TJ, Kempen JH, Sundar Rao PSS, Diener-West M, Courtright P. Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy British Journal of Ophthalmology. 90: 949-954. PMID 16707521 DOI: 10.1136/Bjo.2006.094870  0.413
2006 Daniel E, Ffytche TJ, Sundar Rao PSS, Kempen JH, Diener-West M, Courtright P. Incidence of ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy British Journal of Ophthalmology. 90: 568-573. PMID 16622085 DOI: 10.1136/Bjo.2005.084913  0.392
2006 Kempen JH, Min YI, Freeman WR, Holland GN, Friedberg DN, Dieterich DT, Jabs DA. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 113: 684-94. PMID 16581429 DOI: 10.1016/J.Ophtha.2005.10.067  0.437
2005 Bykhovskaya I, Thorne JE, Kempen JH, Dunn JP, Jabs DA. Vogt-Koyanagi-Harada disease: clinical outcomes. American Journal of Ophthalmology. 140: 674-8. PMID 16226518 DOI: 10.1016/J.Ajo.2005.04.052  0.462
2005 Dunn JP, Yamashita A, Kempen JH, Jabs DA. Retinal vascular occlusion in patients infected with human immunodeficiency virus. Retina (Philadelphia, Pa.). 25: 759-66. PMID 16141865 DOI: 10.1097/00006982-200509000-00012  0.398
2005 Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology. 112: 1472-7. PMID 16061096 DOI: 10.1016/J.Ophtha.2005.02.020  0.412
2005 Thorne JE, Jabs DA, Peters GB, Hair D, Dunn JP, Kempen JH. Birdshot retinochoroidopathy: ocular complications and visual impairment. American Journal of Ophthalmology. 140: 45-51. PMID 16038650 DOI: 10.1016/J.Ajo.2005.01.035  0.426
2005 Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis. American Journal of Ophthalmology. 139: 1028-34. PMID 15953432 DOI: 10.1016/J.Ajo.2005.01.005  0.561
2005 Jabs DA, Holbrook JT, Van Natta ML, Clark R, Jacobson MA, Kempen JH, Murphy RL. Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology. 112: 771-9. PMID 15878056 DOI: 10.1016/J.Ophtha.2004.10.049  0.316
2004 Kuo IC, Kempen JH, Dunn JP, Vogelsang G, Jabs DA. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. American Journal of Ophthalmology. 138: 338-46. PMID 15364214 DOI: 10.1016/J.Ajo.2004.04.015  0.435
2004 Congdon N, Vingerling JR, Klein BEK, West S, Friedman DS, Kempen J, O'Colmain B, Wu S, Taylor HR. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Archives of Ophthalmology. 122: 487-494. PMID 15078665 DOI: 10.1001/Archopht.122.4.487  0.491
2004 Congdon N, O'Colmain B, Klaver CCW, Klein R, Muñoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P. Causes and prevalence of visual impairment among adults in the United States. Archives of Ophthalmology. 122: 477-485. PMID 15078664 DOI: 10.1001/Archopht.122.4.477  0.354
2004 Hubbard LD, Ricks MO, Martin BK, Bressler NM, Kempen JH, Dunn JP, Jabs DA. Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression. American Journal of Ophthalmology. 137: 426-34. PMID 15013864 DOI: 10.1016/J.Ajo.2003.10.002  0.382
2003 Tanna AP, Kempen JH, Dunn JP, Haller JA, Jabs DA. Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis. American Journal of Ophthalmology. 136: 1009-15. PMID 14644210 DOI: 10.1016/S0002-9394(03)00724-4  0.426
2003 Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia J. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 37: 1365-73. PMID 14583871 DOI: 10.1086/379077  0.512
2003 Kempen JH, Martin BK, Wu AW, Barron B, Thorne JE, Jabs DA. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology. 110: 987-95. PMID 12750102 DOI: 10.1016/S0161-6420(03)00089-7  0.365
2003 Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia JA. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Archives of Ophthalmology (Chicago, Ill. : 1960). 121: 466-76. PMID 12695243 DOI: 10.1001/Archopht.121.4.466  0.535
2003 Hylton C, Congdon N, Friedman D, Kempen J, Quigley H, Bass E, Jampel H. Cataract after glaucoma filtration surgery. American Journal of Ophthalmology. 135: 231-232. PMID 12566033 DOI: 10.1016/S0002-9394(02)01919-0  0.374
2003 Jabs DA, Martin BK, Forman MS, Hubbard L, Dunn JP, Kempen JH, Davis JL, Weinberg DV. Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis. American Journal of Ophthalmology. 135: 26-34. PMID 12504693 DOI: 10.1016/S0002-9394(02)01759-2  0.354
2002 Jampel HD, Friedman DS, Lubomski LH, Kempen JH, Quigley H, Congdon N, Levkovitch-Verbin H, Robinson KA, Bass EB. Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review. Ophthalmology. 109: 2215-24; quiz 2225, . PMID 12466161 DOI: 10.1016/S0161-6420(02)01439-2  0.326
2002 Friedman DS, Jampel HD, Lubomski LH, Kempen JH, Quigley H, Congdon N, Levkovitch-Verbin H, Robinson KA, Bass EB. Surgical strategies for coexisting glaucoma and cataract: an evidence-based update. Ophthalmology. 109: 1902-13. PMID 12359612 DOI: 10.1016/S0161-6420(02)01267-8  0.317
2002 Jampel HD, Friedman DS, Lubomski LH, Kempen JH, Quigley H, Congdon N, Levkovitch-Verbin H, Robinson KA, Bass EB. Methodologic rigor of clinical trials on surgical management of eyes with coexisting cataract and glaucoma. Ophthalmology. 109: 1892-901. PMID 12359611 DOI: 10.1016/S0161-6420(02)01084-9  0.331
2002 Jabs DA, Gilpin AM, Min YI, Erice A, Kempen JH, Quinn TC. HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial. Aids (London, England). 16: 877-87. PMID 11919489 DOI: 10.1097/00002030-200204120-00007  0.366
2002 Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, Hubbard LD. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. American Journal of Ophthalmology. 133: 48-61. PMID 11755839 DOI: 10.1016/S0002-9394(01)01322-8  0.376
2001 Kempen JH, Frick KD, Jabs DA. Incremental cost effectiveness of prophylaxis for cytomegalovirus disease in patients with AIDS Pharmacoeconomics. 19: 1199-1208. PMID 11772155 DOI: 10.2165/00019053-200119120-00002  0.336
2001 Friedman DS, Bass EB, Lubomski LH, Fleisher LA, Kempen JH, Magaziner J, Sprintz M, Robinson K, Schein OD. The methodologic quality of clinical trials on regional anesthesia for cataract surgery Ophthalmology. 108: 530-541. PMID 11237907 DOI: 10.1016/S0161-6420(00)00596-0  0.32
2001 Friedman DS, Bass EB, Lubomski LH, Fleisher LA, Kempen JH, Magaziner J, Sprintz M, Robinson K, Schein OD. Synthesis of the literature on the effectiveness of regional anesthesia for cataract surgery Ophthalmology. 108: 519-529. PMID 11237906 DOI: 10.1016/S0161-6420(00)00597-2  0.301
2001 Kempen JH, Jabs DA, Dunn JP, West SK, Tonascia J. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Archives of Ophthalmology (Chicago, Ill. : 1960). 119: 33-40. PMID 11146724  0.483
2000 Nguyen QD, Kempen JH, Bolton SG, Dunn JP, Jabs DA. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy American Journal of Ophthalmology. 129: 634-639. PMID 10844056 DOI: 10.1016/S0002-9394(00)00356-1  0.387
Show low-probability matches.